Retaglutide is a cutting-edge GLP-1 receptor agonist currently under study for the management of metabolic disorders. This drug works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://haseebewms576335.jaiblogs.com/65950662/retaglutide-a-promising-glp-1-receptor-agonist